Eugenie Lumbers

Last updated

Eugenie Ruth Lumbers AM FAA FRSN (also known as Eugenie Forbes) is an Australian medical researcher whose work has focused on the role of the renin-angiotensin system in fetal development and in women's health. [1]

Contents

Career

She earned her MBBS medical degrees and her MD doctorate from the University of Adelaide. She was the first woman to be awarded a CJ Martin Fellowship by the National Health and Medical Research Council of Australia, and with that funding she studied fetal physiology at Oxford University. In 1974 she joined the faculty of University of New South Wales (UNSW). She was awarded the degree of DSc in 1986 and became the first woman appointed as a Scientia Professor at UNSW in 1999. She was elected as Fellow to the Australian Academy of Science and received the Centenary Medal in 2002. In 2010, she was elected a Fellow of the Royal Society of New South Wales. In 2012, she was appointed a Member of the Order of Australia. [2] She received a joint appointment at University of Queensland in 2009 and held that until 2011. She left UNSW in 2013 and received an appointment as a professor at University of Newcastle. [3]

Along with Brian Morris she discovered prorenin, (the protein precursor of renin); her initial findings were met with disbelief from the field, when she began working on it during her doctoral studies. [4] She has studied whether gene therapy could be a viable way to treat congenital diseases during fetal development, and has studied whether drugs that modulate the renin-angiotensis system could be useful to treat endometrial cancer. [1]

Selected publications

Five most-cited papers as of August 2018:

Related Research Articles

ACE inhibitor Class of medications used primarily to treat high blood pressure

Angiotensin-converting-enzyme inhibitors are a class of medication used primarily for the treatment of high blood pressure and heart failure. They work by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart.

Blood pressure Pressure exerted by circulating blood upon the walls of blood vessels

Blood pressure (BP) is the pressure of circulating blood against the walls of blood vessels. Most of this pressure results from the heart pumping blood through the circulatory system. When used without qualification, the term "blood pressure" refers to the pressure in the large arteries. Blood pressure is usually expressed in terms of the systolic pressure over diastolic pressure in the cardiac cycle. It is measured in millimeters of mercury (mmHg) above the surrounding atmospheric pressure.

Renin

Renin, also known as an angiotensinogenase, is an aspartic protease protein and enzyme secreted by the kidneys that participates in the body's renin–angiotensin–aldosterone system (RAAS)—also known as the renin–angiotensin–aldosterone axis—that mediates the volume of extracellular fluid and arterial vasoconstriction. Thus, it regulates the body's mean arterial blood pressure.

Renin–angiotensin system

The renin–angiotensin system (RAS), or renin–angiotensin–aldosterone system (RAAS), is a hormone system that regulates blood pressure and fluid and electrolyte balance, as well as systemic vascular resistance.

Angiotensin

Angiotensin is a peptide hormone that causes vasoconstriction and an increase in blood pressure. It is part of the renin–angiotensin system, which regulates blood pressure. Angiotensin also stimulates the release of aldosterone from the adrenal cortex to promote sodium retention by the kidneys.

Aldosterone Main mineralocorticoid hormone steroid hormone produced by the zona glomerulosa of the adrenal cortex

Aldosterone is the main mineralocorticoid hormone steroid hormone produced by the zona glomerulosa of the adrenal cortex in the adrenal gland. It is essential for sodium conservation in the kidney, salivary glands, sweat glands and colon. It plays a central role in the homeostatic regulation of blood pressure, plasma sodium (Na+), and potassium (K+) levels. It does so primarily by acting on the mineralocorticoid receptors in the distal tubules and collecting ducts of the nephron. It influences the reabsorption of sodium and excretion of potassium (from and into the tubular fluids, respectively) of the kidney, thereby indirectly influencing water retention or loss, blood pressure and blood volume. When dysregulated, aldosterone is pathogenic and contributes to the development and progression of cardiovascular and kidney disease. Aldosterone has exactly the opposite function of the atrial natriuretic hormone secreted by the heart.

Juxtaglomerular apparatus

The juxtaglomerular apparatus is a structure in the kidney that regulates the function of each nephron, the functional units of the kidney. The juxtaglomerular apparatus is named because it is next to (juxta-) the glomerulus.

Antihypertensives are a class of drugs that are used to treat hypertension. Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.

Angiotensin-converting enzyme

Angiotensin-converting enzyme, or ACE, is a central component of the renin–angiotensin system (RAS), which controls blood pressure by regulating the volume of fluids in the body. It converts the hormone angiotensin I to the active vasoconstrictor angiotensin II. Therefore, ACE indirectly increases blood pressure by causing blood vessels to constrict. ACE inhibitors are widely used as pharmaceutical drugs for treatment of cardiovascular diseases.

Essential hypertension is the form of hypertension that by definition has no identifiable secondary cause. It is the most common type affecting 85% of those with high blood pressure. The remaining 15% is accounted for by various causes of secondary hypertension. Primary hypertension tends to be familial and is likely to be the consequence of an interaction between environmental and genetic factors. Prevalence of essential hypertension increases with age, and individuals with relatively high blood pressure at younger ages are at increased risk for the subsequent development of hypertension. Hypertension can increase the risk of cerebral, cardiac, and renal events.

Amniotic fluid

The amniotic fluid is the protective liquid contained by the amniotic sac of a gravid amniote. This fluid serves as a cushion for the growing fetus, but also serves to facilitate the exchange of nutrients, water, and biochemical products between mother and fetus.

Brian James Morris is a professor emeritus of molecular medical sciences at the University of Sydney, Australia.

Losartan

Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. It is also used for diabetic kidney disease, heart failure, and left ventricular enlargement. It is taken by mouth. It may be used alone or in addition to other blood pressure medication. Up to six weeks may be required for the full effects to occur.

In the physiology of the kidney, tubuloglomerular feedback (TGF) is a feedback system inside the kidneys. Within each nephron, information from the renal tubules is signaled to the glomerulus. Tubuloglomerular feedback is one of several mechanisms the kidney uses to regulate glomerular filtration rate (GFR). It involves the concept of purinergic signaling, in which an increased distal tubular sodium chloride concentration causes a basolateral release of adenosine from the macula densa cells. This initiates a cascade of events that ultimately brings GFR to an appropriate level.

Aliskiren

Aliskiren is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension. While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit.

Angiotensin II receptor type 1

Angiotensin II receptor type 1 or AT1 receptor is the best characterized angiotensin receptor. It has vasopressor effects and regulates aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. Angiotensin II receptor antagonists are drugs indicated for hypertension, diabetic nephropathy and congestive heart failure.

Renin inhibitor

Renin inhibitors are pharmaceutical drugs inhibiting the activity of renin that is responsible for hydrolyzing angiotensinogen to angiotensin I, which in turn reducing the formation of angiotensin II that facilitates blood pressure.

Pathophysiology of hypertension

Pathophysiology is a branch of medicine which explains the function of the body as it relates to diseases and conditions. The pathophysiology of hypertension is an area which attempts to explain mechanistically the causes of hypertension, which is a chronic disease characterized by elevation of blood pressure. Hypertension can be classified by cause as either essential or secondary. About 90–95% of hypertension is essential hypertension. Some authorities define essential hypertension as that which has no known explanation, while others define its cause as being due to overconsumption of sodium and underconsumption of potassium. Secondary hypertension indicates that the hypertension is a result of a specific underlying condition with a well-known mechanism, such as chronic kidney disease, narrowing of the aorta or kidney arteries, or endocrine disorders such as excess aldosterone, cortisol, or catecholamines. Persistent hypertension is a major risk factor for hypertensive heart disease, coronary artery disease, stroke, aortic aneurysm, peripheral artery disease, and chronic kidney disease.

Robert Tigerstedt

Robert Adolph Armand Tigerstedt was a Finnish-born medical scientist and physiologist who, with his student Per Bergman, discovered renin at the Karolinska Institute, Stockholm in 1898. Renin is a component of the renin–angiotensin system which regulates blood pressure, salt and water homeostasis and is an important therapeutic target. Tigerstedt is also recognised as an educator, author and social campaigner.

Prorenin is a protein that constitutes a precursor for renin, the hormone that activates the renin–angiotensin system, which serves to raise blood pressure. Prorenin is converted into renin by the juxtaglomerular cells, which are specialised smooth muscle cells present mainly in the afferent, but also the efferent, arterioles of the glomerular capillary bed.

References

  1. 1 2 Morrison, JL; Lumbers, E; Bennet, L; Black, J (November 2013). "Introduction: Celebrating Emeritus Scientia Professor Eugenie R Lumbers AM and Professor Caroline McMillen". Clinical and Experimental Pharmacology & Physiology. 40 (11): 740–2. doi:10.1111/1440-1681.12180. PMID   24117727.
  2. "Emeritus Scientia Professor Eugenie Ruth Lumbers". honours.pmc.gov.au. Retrieved 2019-07-30.
  3. "Professor Eugenie Lumbers". University of Newcastle. 16 January 2015. Retrieved 23 August 2018.
  4. Morris, B. J. (10 January 2011). "2010 Dahl Lecture: Renin, Genes, and Beyond: 40 Years of Molecular Discoveries in the Hypertension Field". Hypertension. 57 (3): 538–548. doi: 10.1161/HYPERTENSIONAHA.110.166967 . PMID   21220705. Open Access logo PLoS transparent.svg